Hillsborough, NJ, United States of America

Bezwada Biomedical, LLC


USPTO Granted Patents = 46

% Expired Patents = 47.8


Trademarks = 5

Forward Citations = 133

Loading Chart...
Loading Chart...

2 inventors (with patents filed for the assignee):

goldMedal Rao S Bezwada (46 out of 152 patents)

silverMedal Neeti Srivastava (1 out of 1 patent)


Core Competencies:
Amino Acid Derivatives
Absorbable Polymers
Bioabsorbable Polyurethanes
Controlled Release
Hydrolysable Linkers
Functionalized Drugs
Biocompatible Polymers
Cross-Linkers
Biodegradable Monomers
Surgical Articles
Phenolic Compounds
Medical Devices

46 patents:

Company Overview
Bezwada Biomedical, LLC, based in Hillsborough, NJ, specializes in the development of advanced biomedical materials and technologies. The company focuses on innovative solutions involving amino acid derivatives, absorbable polymers, and bio-based monomers, which are essential for creating functionalized drugs and biocompatible polyamides. Their expertise in hydrolysable linkers and controlled release systems positions them at the forefront of bioabsorbable polyurethane applications, catering to the evolving needs of the medical device industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Bezwada Biomedical, LLC USPTO Patent Assignee Logo
46 Patents

#2 in Hillsborough, NJ

#312 in New Jersey

#7,597 in US

#15,110 in the World

Hillsborough, NJ (US)
Hillsborough, NJ, United States of America
Forward Citations = 133

2 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bezwada Biomedical, LLC. Retrieved from https://idiyas.com/company/bezwada-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…